StonvexLoading…
StonvexStonvexStonvexCore line items from MYRG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.00B | $3.66B | $2.68B | $1.73B |
Operating Income | $64.72M | $166.87M | $120.35M | $74.08M |
Net Income | $46.80M | $118.42M | $81.87M | $26.47M |
EPS (Diluted) | $2.99 | $7.53 | $5.20 | $3.15 |
Total Assets | $1.67B | $1.64B | $1.65B | $1.59B |
Total Liabilities | $970.61M | $983.66M | $1.03B | $1.00B |
Cash & Equivalents | $163.19M | $150.16M | $76.21M | $22.96M |
Free Cash Flow OCF − CapEx | $68.62M | $232.19M | $147.27M | $81.86M |
Shares Outstanding | 15.57M | 15.52M | 15.52M | 15.52M |